technology

Clinical trial shows gene editing works for β-Thalassaemia, too

arstechnica.com • 09 Apr 2026, 22:28

Clinical trial shows gene editing works for β-Thalassaemia, too

Improved gene editing process reactivates the fetal version of a hemoglobin gene.

Les originalartikkelen

Mere fra arstechnica.com

Sunrise on the Reaping teaser brings us a Second Quarter Quell

Mon 13/04/2026, 20:15
IBM folds to Trump anti-DEI push, admits no misconduct but pays $17M penalty

Mon 13/04/2026, 19:53
Slate Auto raises $650 million as production gets closer and closer

Mon 13/04/2026, 16:35
Meta spins up AI version of Mark Zuckerberg to engage with employees

Mon 13/04/2026, 15:52
To teach in the time of ChatGPT is to know pain

Mon 13/04/2026, 13:00
Shock from Iran war has Trump's vision for US energy dominance flailing

Sun 12/04/2026, 13:17
AI models are terrible at betting on soccer—especially xAI Grok

Sat 11/04/2026, 13:15
The Artemis II mission has ended. Where does NASA go from here?

Sat 11/04/2026, 05:24
Four astronauts are back home after a daring ride around the Moon

Sat 11/04/2026, 03:21

Relaterte artikler etter nøkkelord

gene

editing